SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-004542
Filing Date
2020-04-29
Accepted
2020-04-29 06:48:39
Documents
55
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20200429x10q.htm   iXBRL 10-Q 1511752
2 EX-31.1 qure-20200331xex31d1.htm EX-31.1 18164
3 EX-31.2 qure-20200331xex31d2.htm EX-31.2 18061
4 EX-32.1 qure-20200331xex32d1.htm EX-32.1 11141
  Complete submission text file 0001558370-20-004542.txt   5968546

Data Files

Seq Description Document Type Size
5 EX-101.SCH qure-20200429.xsd EX-101.SCH 43748
6 EX-101.CAL qure-20200429_cal.xml EX-101.CAL 46521
7 EX-101.DEF qure-20200429_def.xml EX-101.DEF 220001
8 EX-101.LAB qure-20200429_lab.xml EX-101.LAB 445776
9 EX-101.PRE qure-20200429_pre.xml EX-101.PRE 349505
53 EXTRACTED XBRL INSTANCE DOCUMENT qure-20200429x10q_htm.xml XML 920026
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 20827257
SIC: 2834 Pharmaceutical Preparations